Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2020-09-14 5:19 pm Purchase | 13D | I-MAB SPONSORED ADS IMAB | HHLR ADVISORS LTD. | 10,586,008 6.8% | 10,586,008 (New Position) | View |
| 2020-07-14 09:01 am Purchase | 13D | BEIGENE LTD SPONSORED ADR BGNE | HHLR ADVISORS LTD. | 147,035,258 12.7% | 83,917,869 (+132.96%) | View |
| 2020-06-24 4:38 pm Unchanged | 13D | CELLULAR BIOMEDICINE GROUP, IN CBMG | HHLR ADVISORS LTD. | 235,214 1.2% | 0 (Unchanged) | View |
| 2020-05-08 4:30 pm Unchanged | 13D | CHINA BIOLOGIC PRODS HLDGS INC CBPO | HHLR ADVISORS LTD. | 2,962,076 7.7% | 0 (Unchanged) | View |
| 2020-03-30 4:15 pm Unchanged | 13D | CELLULAR BIOMEDICINE GROUP, IN CBMG | HHLR ADVISORS LTD. | 235,214 1.2% | 0 (Unchanged) | View |
| 2020-02-21 4:10 pm Unchanged | 13D | CELLULAR BIOMEDICINE GROUP, IN CBMG | HHLR ADVISORS LTD. | 235,214 1.2% | 0 (Unchanged) | View |
| 2020-02-14 4:34 pm Purchase | 13G | VIELA BIO INC VIE | HHLR ADVISORS LTD. | 4,591,176 9% | 4,591,176 (New Position) | View |
| 2020-02-14 4:29 pm Purchase | 13G | GOSSAMER BIO INC GOSS | HHLR ADVISORS LTD. | 5,911,541 9% | 5,911,541 (New Position) | View |
| 2020-02-14 4:28 pm Purchase | 13G | APELLIS PHARMACEUTICALS INC CO APLS | HHLR ADVISORS LTD. | 4,678,289 7.3% | 2,448,581 (+109.82%) | View |
| 2020-02-14 4:27 pm Purchase | 13G | BILIBILI INC ADS REPSTG SHS CL BILI | HHLR ADVISORS LTD. | 10,215,355 4.5% | 10,215,355 (New Position) | View |
| 2020-02-14 4:27 pm Purchase | 13G | TAL EDUCATION GROUP ADS REPSTG TAL | HHLR ADVISORS LTD. | 9,151,656 6.9% | 9,151,656 (New Position) | View |
| 2020-02-14 4:24 pm Purchase | 13G | MOGU INC ADR MOGU | HHLR ADVISORS LTD. | 261,174,255 11% | 130,587,128 (+100.00%) | View |
| 2020-02-14 4:24 pm Purchase | 13G | KINIKSA PHARMACEUTICALS LTD KNSA | HHLR ADVISORS LTD. | 1,895,888 9.9% | 507,000 (+36.50%) | View |
| 2020-02-14 4:23 pm Purchase | 13G | IQIYI INC SPONSORED ADR IQ | HHLR ADVISORS LTD. | 326,862,409 14.9% | 318,932,697 (+4022.00%) | View |
| 2020-01-30 09:17 am Unchanged | 13D | CELLULAR BIOMEDICINE GROUP, IN CBMG | HHLR ADVISORS LTD. | 235,214 1.2% | 0 (Unchanged) | View |
| 2020-01-27 4:05 pm Purchase | 13D | CHINA BIOLOGIC PRODS HLDGS INC CBPO | HHLR ADVISORS LTD. | 2,962,076 7.7% | 210,876 (+7.66%) | View |
| 2019-11-12 08:00 am Purchase | 13D | CELLULAR BIOMEDICINE GROUP, IN CBMG | HHLR ADVISORS LTD. | 235,214 1.2% | 235,214 (New Position) | View |
| 2019-09-19 4:30 pm Unchanged | 13D | CHINA BIOLOGIC PRODS HLDGS INC CBPO | HHLR ADVISORS LTD. | 2,751,200 7.2% | 0 (Unchanged) | View |